Gagelmann, N., Bishop, M., Ayuk, F., Bethge, W., Glass, B., Sureda, A., . . . Kröger, N. (2024). Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis.
Citación estilo ChicagoGagelmann, Nico, Michael Bishop, Francis Ayuk, Wolfgang Bethge, Bertram Glass, Anna Sureda, Marcelo C. Pasquini, y Nicolaus Kröger. Axicabtagene Ciloleucel Versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis. 2024.
Cita MLAGagelmann, Nico, et al. Axicabtagene Ciloleucel Versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis. 2024.
Precaución: Estas citas no son 100% exactas.